Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GNL3L mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of GNL3L mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GNL3L mRNA | decreases expression | 20018196
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GNL3L mRNA | decreases expression | 20106945
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of GNL3L mRNA | affects expression | 17440010
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.49 | 7525203 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.11 | 16675129 12948864 17018787 17289903 18497071 17261762 19861407 14630087 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.00 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.09 | 16924424 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.81 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.44 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.44 | 18566989 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.49 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.50 | 18551238 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.74 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.38 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
4.38 | 21346803 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.20 | 18566989 11473722 19148513 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.64 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.36 | 17440010 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.36 | 17088409 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.18 | 16627594 16393666 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.76 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.39 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.39 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14659978 14716833 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.77 | 11408345 11807958 17203775 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.09 | 19453300 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.55 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.40 | 18551238 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.27 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.09 | 11399458 16427766 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.31 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
10.31 | 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.30 | 19401270 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.26 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.03 | 16740699 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.76 | 18551238 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.30 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.39 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.86 | 10091137 |